Professor Fang: Wang Naiping Researcher: Tan.

Ginseng l5g Angelica l5g Peach Kernel 10g Safflower 10g Sumu l5g Xue Tong l5g

Yujin 10g dandelion 20g zedoary 10g kelp 20g Tianqi 5g artillery armor 10g

Salvia miltiorrhiza l5g Dipsacus l5g Sparganum 10g Goose Tube Stone 15g Paeonia Rubra 10g seaweed 20g.

Chuanxiong rhizome 10g Achyranthes bidentata 9g gecko l5g Radix Isatidis 15g Rhizoma corydalis 10g Prunella vulgaris 25g

Viola yedoensis l5g

On the basis of this medicine, according to the different pathogenesis of various cancers and tumors, it has good curative effect on esophageal cancer, gastric cancer, lung cancer, liver cancer, intestinal cancer, uterine cancer, pancreatic cancer, lymphoma, leukemia, nasal cancer and so on.

The medicine has the effects of promoting blood circulation, removing blood stasis, dredging channels and collaterals, removing blood stasis, promoting tissue regeneration, softening channels and collaterals, and improving immune function, and has no toxic or side effects. It is suitable for all kinds of cancer patients, so as to improve the symptoms of tumor patients, make the tumor shrink and disappear gradually, inhibit tumor metastasis, enhance the immunity of patients and improve the survival rate of tumor patients.

The clinical efficacy of this medicine is shown in the following table:

cerebroma

esophagus cancer

gastric cancer

lung cancer

Tracheal carcinoma

Hepatobiliary hepatocellular carcinoma

liver cancer

metrocarcinoma

disease

example

count

have

affect

speed

disease

example

count

have

affect

speed

disease

example

count

have

affect

speed

disease

example

count

have

affect

speed

disease

example

count

have

affect

speed

disease

example

count

have

affect

speed

disease

example

count

have

affect

speed

disease

example

count

have

affect

speed

15

85%

Seventy-eight

85%

84

90%

74

90%

58

98%

3 1

92%

27

85%

93

95%

ovarian tumor

rectal cancer

osteocarcinoma

thyroid cancer

pancreatic cancer

lymph cancer

breast cancer

rhino-carcinoma

disease

example

count

have

affect

speed

disease

example

count

have

affect

speed

disease

example

count

have

affect

speed

disease

example

count

have

affect

speed

disease

example

count

have

affect

speed

disease

example

count

have

affect

speed

disease

example

count

have

affect

speed

disease

example

count

have

affect

speed

87

95%

25

90%

17

90%

34

90%

45

90%

124

93%

53

90%

37

90%

For patients with early and middle stage tumors, this medicine is an aqueous solution, each time 100ml, three times a day, and one month is a course of treatment; Capsule three times a day, 4-6 capsules each time, one month as a course of treatment;

For patients with advanced malignant tumor, this medicine is: 200 ml aqueous solution, three times a day, one month as a course of treatment; Capsule 3 times a day, 8 capsules each time, one month as a course of treatment. Patients should not eat during medication; Raw cold, preserved eggs, tobacco and alcohol, peppers, etc.